Safety and efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A multi-center, randomized, placebo-controlled, double-blinded trial

Authors

Michael G Fehlings, University of Toronto
Wilson Z Ray, Washington University School of Medicine in St. Louis
et al.

Journal

Journal of Neurotrauma

Publication Date

9-1-2023

Volume

40

Issue

17-18

First Page

1878

Last Page

1888

Document Type

Open Access Publication

DOI

10.1089/neu.2023.0163

Rights and Permissions

Fehlings MG, Moghaddamjou A, Harrop JS, Stanford R, Ball J, Aarabi B, Freeman BJC, Arnold PM, Guest JD, Kurpad SN, Schuster JM, Nassr A, Schmitt KM, Wilson JR, Brodke DS, Ahmad FU, Yee A, Ray WZ, Brooks NP, Wilson J, Chow DS, Toups EG, Kopjar B. Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial. J Neurotrauma. 2023 Sep;40(17-18):1878-1888. doi: 10.1089/neu.2023.0163. This Open Access article is distributed under the terms of the Creative Commons License (CC-BY) (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

Recommended Citation

Fehlings, Michael G; Ray, Wilson Z; and et al., "Safety and efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A multi-center, randomized, placebo-controlled, double-blinded trial." Journal of Neurotrauma. 40, 17-18. 1878 - 1888. (2023).
https://digitalcommons.wustl.edu/oa_4/2208

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.